Sheba Medical Center and Enlivex Announce Dosing of the First Patient in Phase I/II Trial Evaluating Allocetra Combined with Chemotherapy in Patients with Peritoneal Metastases Arising from Solid Cancers
Similar Posts
Meet Expanse: MEDITECH’s Next-Generation Platform
MEDITECH delivers a web-based EHR for the new healthcare paradigm MEDITECH, a leading Enterprise Health Record (EHR) vendor, is…
Premier Inc. Selects RXTransparent Compliance Solution to Address DSCSA Compliance for Hospital and Healthcare Providers
The first drug supply chain tracking solution to go “beyond the loading dock” now available to over 130,000 Premier…
Community Care Collaborative Selects Bridge Patient Portal for Patient-Centered Engagement, Spanish Translation and Responsive Mobile Design
Texas Healthcare Organization Achieves Twice the National Patient Enrollment Average Using Bridge Patient Portal Serving the 11th largest metro-area in the…
Withings Becomes National Sponsor of Project Power from the American Diabetes Association and Will Distribute Body Comp Smart Scale to Participants
Withings groundbreaking Body Comp Scale helps the American Diabetes Association Project Power participants increase awareness and management of…
